K834464 is an FDA 510(k) clearance for the TDX PROCAINAMIDE. This device is classified as a Enzyme Immunoassay, Procainamide (Class II - Special Controls, product code LAR).
Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on February 3, 1984, 45 days after receiving the submission on December 20, 1983.
This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3320.
| 510(k) Number | K834464 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | December 20, 1983 |
| Decision Date | February 03, 1984 |
| Days to Decision | 45 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
| Product Code | LAR — Enzyme Immunoassay, Procainamide |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.3320 |